Research is being conducted on treatments for moderate-to-severe plaque psoriasis, including the use of biologics such as risankizumab and bimekizumab. Some studies suggest that these treatments may lead to long-term control and durable clearance of psoriasis symptoms. The effectiveness of these treatments is being explored in various clinical trials and real-world data, with some reports indicating promising results.